Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
| Autor: | Alicia Ramirez-Fernandez, J L Guerrero Orriach, Manuel Rubio-Navarro, Jose Cruz-Mañas, J J Escalona-Belmonte |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Inotrope
Drug medicine.medical_specialty Cardiotonic Agents media_common.quotation_subject Vasodilator Agents Clinical Decision-Making Vasodilation 030204 cardiovascular system & hematology Calcium sensitizer Drug Administration Schedule Perioperative Care 03 medical and health sciences 0302 clinical medicine Postoperative Complications Risk Factors Medicine Animals Humans Cardiac Surgical Procedures Simendan media_common Pharmacology Heterogeneous group business.industry Patient Selection Levosimendan Cardiac surgery Regimen Treatment Outcome Anesthesia Cardiology and Cardiovascular Medicine business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Current vascular pharmacology. 16(4) |
| ISSN: | 1875-6212 |
| Popis: | Inodilators are a heterogeneous group of drugs with vasodilatory and inotropic effects. The cardioprotective effect of levosimendan is multifactorial, but now research on levosimendan is focused on the organ-protective properties of this drug in different settings, the regimen that seems to provide the greatest cardiologic and systemic benefits is early administration of levosimendan. We try to answer four questions in this review, which type of patients need this drug? what is the best time to start with it? and the best way that we could give it and finally the reasons for use it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|